Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.6 [0.44-0.81],0.000999807221095246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.79 [0.67-0.93],0.00364822013757754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.19 [1.06-1.33],0.0041572765301173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.26 [1.06-1.49],0.00859857129378758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NRP1,Neuropilin-1,Inverse variance weighted,12,0.77 [0.63-0.94],0.0100839941347023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.63 [1.12-2.39],0.0116974139063186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.82 [0.7-0.96],0.0142089640125276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH15,Cadherin-15,Inverse variance weighted,18,0.83 [0.72-0.97],0.0176855635882378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.91 [0.84-0.99],0.0199237489361127,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.19 [0.05-0.78],0.0214930521178034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD70,CD70 antigen,Inverse variance weighted,28,0.89 [0.81-0.98],0.0220295715649584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPON2,Spondin-2,Inverse variance weighted,4,1.35 [1.03-1.77],0.0288593508986682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.14 [1.01-1.29],0.0302870806062079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LCN15,Lipocalin-15,Inverse variance weighted,20,0.9 [0.82-0.99],0.0333314461255873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.67 [0.46-0.97],0.0350081690942722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LGALS4,Galectin-4,Inverse variance weighted,4,0.67 [0.46-0.99],0.0419529156305443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NECTIN2,Nectin-2,Inverse variance weighted,5,1.21 [1.01-1.46],0.0437831941300407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SEPTIN8,Septin-8,Inverse variance weighted,2,1.56 [1.01-2.41],0.0441121004282641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SDC1,Syndecan-1,Inverse variance weighted,2,1.62 [1.01-2.58],0.0444604288358068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.14 [1-1.3],0.0457792155274379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.8 [0.63-1],0.0464484622819923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.68 [1.01-2.8],0.0476304814791214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.35 [1-1.82],0.0482697866182319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.84 [0.7-1],0.0523268200438344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AGRN,Agrin,Inverse variance weighted,17,1.2 [1-1.45],0.0544123225014983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.62 [0.38-1.01],0.0553748283808207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.12 [1-1.26],0.0575426027269185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.07 [1-1.16],0.0586106243656134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.5 [0.25-1.03],0.0600361312167957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.89 [0.79-1.01],0.060837573398977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.5 [0.98-2.29],0.0611682635473236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.61 [0.37-1.02],0.0616790036565297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.61 [0.97-2.7],0.068109653404056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.64 [0.4-1.04],0.0718598732130033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,OCLN,Occludin,Inverse variance weighted,2,1.53 [0.96-2.43],0.0753146041400694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DPT,Dermatopontin,Inverse variance weighted,21,1.15 [0.98-1.35],0.0766489789699481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.89 [0.79-1.01],0.0781809467486764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,10,0.88 [0.77-1.01],0.0784093090299366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.17 [0.98-1.39],0.0797220096496298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.73 [0.51-1.04],0.082686519322905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.88 [0.77-1.02],0.0830212072892102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.17 [0.98-1.39],0.0868960551986842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.13 [0.98-1.31],0.0892673946216364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.21 [0.96-1.53],0.0990696560070752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.14 [0.98-1.33],0.100941565028346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD46,Membrane cofactor protein,Wald ratio,1,1.77 [0.89-3.53],0.104223217889036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.89 [0.76-1.03],0.106276913906643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.13 [0.97-1.31],0.109980256056101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.23 [0.95-1.6],0.113666697176429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCN4,CCN family member 4,Inverse variance weighted,27,1.1 [0.98-1.25],0.114513889577233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,0.8 [0.61-1.06],0.119185631272641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH17,Cadherin-17,Inverse variance weighted,14,0.87 [0.73-1.04],0.120424290053446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PSAP,Prosaposin,Inverse variance weighted,5,0.81 [0.62-1.06],0.121004571898512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD276,CD276 antigen,Inverse variance weighted,20,1.08 [0.98-1.2],0.121271763564721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.05 [0.99-1.12],0.122964658548718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.26 [0.94-1.71],0.125139798742624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,UMOD,Uromodulin,Inverse variance weighted,29,0.94 [0.87-1.02],0.131252951991213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.17 [0.95-1.42],0.13197222974682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.3 [0.06-1.48],0.140911119820724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.48 [0.87-2.51],0.147125476704634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,OGN,Mimecan,Inverse variance weighted,30,0.91 [0.81-1.03],0.147133926006512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.91 [0.81-1.03],0.148161821463954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.1 [0.97-1.26],0.148816765425591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PENK,Proenkephalin-A,Inverse variance weighted,19,1.18 [0.94-1.48],0.149041058877102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.86 [0.71-1.05],0.151337174785851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.88 [0.74-1.05],0.152547107074312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.9 [0.77-1.04],0.153755090359963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EDN1,Endothelin-1,Inverse variance weighted,3,1.3 [0.9-1.86],0.156633147289238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.73 [0.48-1.13],0.159150511841388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.69 [0.41-1.16],0.163436818482075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.17 [0.94-1.45],0.164866825259563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.87 [0.72-1.06],0.165009020677569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.83 [0.63-1.08],0.166904497678896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.34 [0.88-2.02],0.169232988004742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.24 [0.91-1.69],0.169412511818562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PALM2,Paralemmin-2,Inverse variance weighted,8,1.22 [0.92-1.61],0.169613260418081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.87 [0.71-1.06],0.170097051743795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.12 [0.95-1.33],0.170604730366109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.09 [0.96-1.22],0.174581399247201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.4 [0.1-1.51],0.175422761662796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.51 [0.19-1.35],0.175586194551684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.33 [0.88-2],0.177202102266493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.31 [0.88-1.94],0.177213901893153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.06 [0.97-1.15],0.178354653896495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.54 [0.22-1.33],0.180748120180652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.13 [0.94-1.36],0.183834216071303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,12,0.81 [0.6-1.11],0.189587255842944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.91 [0.79-1.05],0.19113359166141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.93 [0.84-1.03],0.191215815239777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MUC13,Mucin-13,Inverse variance weighted,9,0.85 [0.67-1.08],0.191882703558183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,0.96 [0.9-1.02],0.194233053211065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.58 [0.26-1.32],0.194657327982521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.95 [0.87-1.03],0.195446459343769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FCN1,Ficolin-1,Inverse variance weighted,28,0.92 [0.81-1.04],0.195523825288166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.93 [0.84-1.04],0.196043105681681,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Wald ratio,1,0.33 [0.06-1.79],0.19744326470699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.9 [0.77-1.06],0.19894616821777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.77 [0.52-1.15],0.201941138594649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.85 [0.66-1.09],0.204933512569237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.83 [0.62-1.11],0.212085664104575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GUCA2A,Guanylin,Inverse variance weighted,9,1.19 [0.91-1.56],0.213102361893874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.89 [0.73-1.07],0.215054437552194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.63 [0.3-1.32],0.216458650250016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PALM,Paralemmin-1,Inverse variance weighted,6,0.82 [0.61-1.12],0.216516289124468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.21 [0.89-1.65],0.217748975839322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.58 [0.76-3.28],0.221535709927527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.41 [0.81-2.47],0.224284159764472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GSN,Gelsolin,Inverse variance weighted,5,1.43 [0.8-2.56],0.224362024572818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.91 [0.78-1.06],0.22517280292673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NOMO1,Nodal modulator 1,Inverse variance weighted,2,0.79 [0.53-1.16],0.225519425699518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RETN,Resistin,Inverse variance weighted,9,0.92 [0.81-1.05],0.228646990365172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.76 [0.49-1.19],0.228722758232108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TMPRSS15,Enteropeptidase,Inverse variance weighted,3,0.76 [0.48-1.19],0.231460371062707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.93 [0.82-1.05],0.232436611505367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LGALS9,Galectin-9,Inverse variance weighted,26,0.92 [0.8-1.06],0.23868593284583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSL,Cathepsin L1,Wald ratio,1,2.19 [0.59-8.21],0.243780188591709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.9 [0.75-1.08],0.245433100180205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLK4,Kallikrein-4,Inverse variance weighted,17,1.09 [0.94-1.27],0.245604494612374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.84 [0.62-1.13],0.247973941177104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CFD,Complement factor D,Inverse variance weighted,11,1.15 [0.91-1.44],0.249803668193735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.18 [0.89-1.56],0.257279453719731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.84 [0.63-1.13],0.257695916014805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD302,CD302 antigen,Inverse variance weighted,9,0.87 [0.68-1.11],0.258841152215319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.91 [0.78-1.07],0.25923795385203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NECTIN4,Nectin-4,Inverse variance weighted,7,0.9 [0.75-1.08],0.264996260728704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.92 [0.8-1.06],0.268802628691512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CPA2,Carboxypeptidase A2,Inverse variance weighted,17,0.92 [0.79-1.07],0.270341885644442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.12 [0.91-1.37],0.275729871180847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.66 [0.66-4.17],0.282056240531458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.15 [0.89-1.49],0.287781929037416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.94 [0.83-1.06],0.288587206995864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.08 [0.93-1.26],0.289620308994589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.13 [0.9-1.42],0.291839683260341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.17 [0.87-1.58],0.29343244862808,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.55 [0.18-1.68],0.293673656111076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.82 [0.56-1.19],0.297739099661965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.13 [0.9-1.42],0.297809805647613,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.37 [0.75-2.5],0.303369242302927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.11 [0.91-1.36],0.305455000439869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.13 [0.89-1.44],0.307388723449677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.94 [0.83-1.06],0.308119721407121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.87 [0.68-1.13],0.308219728344185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1.07 [0.94-1.23],0.310025209807183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PVR,Poliovirus receptor,Inverse variance weighted,27,0.95 [0.87-1.05],0.314253068097607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.04 [0.97-1.11],0.31571430486193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,0.94 [0.83-1.06],0.317323479088859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.75 [0.42-1.32],0.320583680683911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITGB7,Integrin beta-7,Inverse variance weighted,3,1.13 [0.89-1.43],0.321551448112768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.4 [0.07-2.43],0.321833595265881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MILR1,Allergin-1,Inverse variance weighted,33,0.97 [0.9-1.04],0.326265075591479,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.88 [0.69-1.13],0.326623961056045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.4 [0.71-2.77],0.328890262821019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.72 [0.37-1.4],0.330310633663366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,0.91 [0.76-1.1],0.331476230524848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.47 [0.1-2.2],0.340661095007581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITGB2,Integrin beta-2,Inverse variance weighted,4,0.85 [0.6-1.19],0.341453831187625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRSS8,Prostasin,Inverse variance weighted,5,0.81 [0.53-1.25],0.341591094137104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AMBP,Protein AMBP,Inverse variance weighted,3,0.79 [0.49-1.28],0.346478319768125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.76 [0.43-1.35],0.348955827273206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.94 [0.84-1.06],0.349241802153176,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.54 [0.14-1.99],0.35112902748842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.61 [0.2-1.79],0.363958480233905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.95 [0.86-1.06],0.364517228270688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.91 [0.75-1.11],0.365242828527139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.03 [0.96-1.11],0.365680684791163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.18 [0.82-1.71],0.367329184106824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.95 [0.86-1.06],0.3706302040754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.72 [0.35-1.49],0.376370945768565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.11 [0.88-1.38],0.377264261806581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BCAN,Brevican core protein,Inverse variance weighted,3,0.89 [0.69-1.15],0.378749463227882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.82 [0.52-1.29],0.381003296587299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NCAN,Neurocan core protein,Inverse variance weighted,3,0.83 [0.55-1.25],0.381201948774057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.8 [0.49-1.31],0.381757789741565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLK11,Kallikrein-11,Inverse variance weighted,6,0.91 [0.74-1.12],0.38242916558026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSS,Cathepsin S,Inverse variance weighted,23,0.94 [0.82-1.08],0.387492846883215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.04 [0.95-1.15],0.387890563152799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.13 [0.85-1.5],0.389723696946023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.18 [0.81-1.7],0.390222481766575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,1.05 [0.94-1.17],0.390458113202242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.7 [0.31-1.57],0.390501602065325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,2.17 [0.37-12.64],0.390590940413247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NFASC,Neurofascin,Inverse variance weighted,15,0.94 [0.8-1.09],0.391300026078187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.91 [0.74-1.12],0.394001184771793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,INSR,Insulin receptor,Wald ratio,1,0.6 [0.18-1.99],0.399335563719635,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,0.97 [0.92-1.04],0.403797652347449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.54 [0.54-4.38],0.414699171737492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRTG,Protogenin,Inverse variance weighted,19,1.05 [0.94-1.17],0.417016995707108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BSG,Basigin,Wald ratio,1,1.2 [0.77-1.87],0.418747533512339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1.09 [0.89-1.34],0.419241540295815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,INHBC,Inhibin beta C chain,Inverse variance weighted,29,0.96 [0.86-1.06],0.423232215177458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL18,Interleukin-18,Inverse variance weighted,16,1.16 [0.81-1.66],0.424502014686466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.02 [0.97-1.09],0.424702381548054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.1 [0.87-1.38],0.426894392127184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.86 [0.58-1.26],0.428490353947161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CALCA,Calcitonin,Inverse variance weighted,5,1.22 [0.74-2.01],0.42873041773755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PYY,Peptide YY,Inverse variance weighted,6,1.11 [0.85-1.45],0.436495508380725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.95 [0.83-1.08],0.437203668646731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.05 [0.92-1.2],0.440894172424866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.5 [0.54-4.19],0.441172103894265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,1.15 [0.8-1.66],0.446319605119373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.84 [0.53-1.32],0.446600827174993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.06 [0.91-1.25],0.448812406366524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RSPO3,R-spondin-3,Inverse variance weighted,6,1.13 [0.82-1.55],0.449715155133376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MFGE8,Lactadherin,Inverse variance weighted,11,0.93 [0.78-1.12],0.450535867914119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PI3,Elafin,Inverse variance weighted,10,0.93 [0.78-1.12],0.452917272430119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.93 [0.76-1.13],0.453336780822117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD109,CD109 antigen,Inverse variance weighted,45,1.03 [0.96-1.11],0.455177534671494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.87 [0.61-1.25],0.461516117099804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.87 [0.61-1.25],0.461989463498017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.9 [0.68-1.19],0.462045116505489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACY1,Aminoacylase-1,Inverse variance weighted,4,1.15 [0.79-1.66],0.463730935614971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.1 [0.86-1.4],0.468790825255678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.1 [0.84-1.44],0.472948200053744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.97 [0.9-1.05],0.477563570782885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CST3,Cystatin-C,Inverse variance weighted,10,1.12 [0.82-1.52],0.477707962770107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.92 [0.72-1.17],0.479050005771892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.06 [0.9-1.25],0.479104000845922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.05 [0.92-1.2],0.482751360682219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.15 [0.78-1.69],0.483983318702811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,0.79 [0.4-1.54],0.486381392015443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHAD,Chondroadherin,Inverse variance weighted,3,1.07 [0.89-1.28],0.488090620390373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.92 [0.73-1.17],0.491981272402826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD160,CD160 antigen,Inverse variance weighted,11,1.05 [0.91-1.22],0.493352193203131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GRN,Progranulin,Inverse variance weighted,7,0.91 [0.7-1.19],0.494223690441226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.54 [0.09-3.22],0.499586183026182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1.05 [0.91-1.21],0.504281017879436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPON1,Spondin-1,Inverse variance weighted,21,1.05 [0.91-1.22],0.505411595802288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHGB,Secretogranin-1,Inverse variance weighted,27,1.03 [0.93-1.14],0.509968360537875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.96 [0.84-1.09],0.516061783580481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,19,0.95 [0.83-1.1],0.522258655963768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MME,Neprilysin,Inverse variance weighted,3,0.79 [0.37-1.65],0.522586374530581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PKD1,Polycystin-1,Inverse variance weighted,12,0.94 [0.76-1.15],0.523929821131332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.69 [0.22-2.16],0.525887731062949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.89 [0.62-1.28],0.528150142662404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.92 [0.71-1.19],0.528322413792696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.88 [0.58-1.33],0.528956280878686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.09 [0.83-1.43],0.53486980675409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.94 [0.77-1.14],0.535898091772814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD164,Sialomucin core protein 24,Inverse variance weighted,3,0.89 [0.61-1.29],0.539562088956246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.94 [0.76-1.15],0.541680654345365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ALCAM,CD166 antigen,Inverse variance weighted,6,0.89 [0.6-1.3],0.542838355278921,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.92 [0.71-1.2],0.542971861754959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.9 [0.64-1.26],0.546101270108905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.04 [0.92-1.17],0.547554362702397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,0.93 [0.73-1.18],0.548616268609791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.95 [0.8-1.13],0.551614367473763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.96 [0.84-1.1],0.552100138625748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PGF,Placenta growth factor,Inverse variance weighted,2,0.63 [0.13-2.97],0.554865651796882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.06 [0.87-1.28],0.56177956204895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.22 [0.62-2.4],0.564894067314388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.03 [0.94-1.12],0.566728174785702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.91 [0.64-1.27],0.56760016154823,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1.13 [0.75-1.7],0.572374337772568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LAYN,Layilin,Inverse variance weighted,20,1.06 [0.86-1.3],0.573408216571244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TLR1,Toll-like receptor 1,Inverse variance weighted,16,0.95 [0.79-1.14],0.575240154610968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.08 [0.82-1.44],0.575400700822458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.04 [0.9-1.21],0.579812558982709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,1.04 [0.9-1.21],0.582972311278448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.93 [0.71-1.21],0.583377021866789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.19 [0.64-2.2],0.585353616129938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGSF9,Protein turtle homolog A,Inverse variance weighted,10,0.95 [0.78-1.15],0.589299139283908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.04 [0.9-1.21],0.5894219041927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SELE,E-selectin,Inverse variance weighted,4,1.25 [0.55-2.87],0.591071869631898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.04 [0.89-1.22],0.591177973406584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.95 [0.79-1.15],0.59258122634806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.03 [0.93-1.14],0.592643969016581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.17 [0.66-2.09],0.594377087871455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CR1,Complement receptor type 1,Inverse variance weighted,21,1.03 [0.92-1.17],0.600399765176133,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.86 [0.49-1.52],0.606103237087321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.06 [0.86-1.29],0.606265877803936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.88 [0.56-1.41],0.607117063117262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.2 [0.59-2.44],0.609980135273958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.89 [0.55-1.42],0.612968370748716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1.05 [0.86-1.28],0.616890321944357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.06 [0.83-1.37],0.620254664818401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.03 [0.91-1.17],0.622046725671819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.13 [0.69-1.84],0.623817261611425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.9 [0.57-1.4],0.629680240312619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.09 [0.77-1.54],0.630222548747943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.9 [0.59-1.37],0.631302236120062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD27,CD27 antigen,Inverse variance weighted,9,1.04 [0.87-1.25],0.632977146507343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH1,Cadherin-1,Wald ratio,1,0.73 [0.2-2.7],0.633367678353031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SCG2,Secretogranin-2,Wald ratio,1,1.37 [0.38-4.97],0.635323299983466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DSC2,Desmocollin-2,Inverse variance weighted,9,1.05 [0.86-1.29],0.638979034997755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.85 [0.44-1.67],0.641862527581266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.02 [0.92-1.14],0.644751325258919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,APOF,Apolipoprotein F,Inverse variance weighted,3,0.92 [0.64-1.32],0.645360543464632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,1.33 [0.39-4.48],0.647797874855991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.84 [0.4-1.77],0.653113183263885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.1 [0.73-1.66],0.653794738484402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.1 [0.72-1.7],0.654024171296766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MVK,Mevalonate kinase,Inverse variance weighted,2,0.86 [0.45-1.66],0.658122714761476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.91 [0.59-1.4],0.660018620788937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,4,0.94 [0.7-1.26],0.668822668990953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.77 [0.23-2.57],0.670009112766268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.02 [0.94-1.1],0.670348322580835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.02 [0.93-1.12],0.670669479439046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.03 [0.89-1.19],0.674763984135731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.97 [0.83-1.13],0.677425498343205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.02 [0.91-1.15],0.678515019756054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.02 [0.94-1.09],0.68146862549966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.75 [0.19-2.94],0.681884736305437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.03 [0.88-1.22],0.690048362314627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.95 [0.75-1.21],0.693139287293618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRELP,Prolargin,Inverse variance weighted,9,0.96 [0.8-1.16],0.695226258346534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.12 [0.63-1.99],0.696393685808115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CPM,Carboxypeptidase M,Inverse variance weighted,4,0.89 [0.49-1.62],0.698880155940939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.9 [0.54-1.51],0.700468369618822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.06 [0.8-1.39],0.703453499558905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSD,Cathepsin D,Inverse variance weighted,17,1.03 [0.87-1.23],0.70961107020954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,1.02 [0.9-1.17],0.714127479360581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHGA,Chromogranin-A,Inverse variance weighted,3,1.06 [0.78-1.44],0.718524717414313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.06 [0.78-1.44],0.719638354647519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.96 [0.77-1.2],0.720695468244664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.77 [0.18-3.24],0.723368225547337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DRAXIN,Draxin,Inverse variance weighted,13,1.02 [0.9-1.16],0.723626609544228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,1.02 [0.91-1.14],0.72460010668821,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AREG,Amphiregulin,Inverse variance weighted,3,0.93 [0.63-1.39],0.727791172511428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MMP7,Matrilysin,Inverse variance weighted,13,0.96 [0.76-1.21],0.732266972831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.97 [0.8-1.17],0.733739084837994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.03 [0.87-1.22],0.737020968776491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,0.94 [0.64-1.37],0.73728728553587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.93 [0.59-1.45],0.737846813880963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,0.9 [0.49-1.65],0.741970656056842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.03 [0.88-1.19],0.742800697346209,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.03 [0.87-1.21],0.743376504330304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MDK,Midkine,Inverse variance weighted,4,1.07 [0.72-1.59],0.744122793416144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MMP10,Stromelysin-2,Inverse variance weighted,22,1.03 [0.87-1.21],0.745929079661895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CR2,Complement receptor type 2,Inverse variance weighted,6,0.92 [0.54-1.56],0.746233507046139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,THBD,Thrombomodulin,Inverse variance weighted,5,1.05 [0.78-1.41],0.748735575536372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.91 [0.5-1.65],0.751757501937155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.94 [0.62-1.41],0.755250614233236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.12 [0.53-2.36],0.758592597376834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COLEC12,Collectin-12,Inverse variance weighted,11,1.04 [0.79-1.37],0.760453990413944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.03 [0.84-1.27],0.761552421747325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.05 [0.74-1.5],0.765675138354332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.09 [0.63-1.88],0.768732862633842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.98 [0.86-1.12],0.770763436482222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.97 [0.77-1.22],0.775580974394856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BOC,Brother of CDO,Inverse variance weighted,6,1.04 [0.78-1.38],0.780589562454598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.03 [0.82-1.3],0.784033305882094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.98 [0.85-1.13],0.78543198504511,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.06 [0.7-1.6],0.788946965087594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.98 [0.81-1.17],0.789775021603982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.99 [0.88-1.1],0.792012152562688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.01 [0.91-1.13],0.793136493472659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.96 [0.73-1.27],0.797365004056361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSO,Cathepsin O,Inverse variance weighted,6,0.97 [0.73-1.28],0.80454622534506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.98 [0.82-1.16],0.807845394110691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL19,Interleukin-19,Inverse variance weighted,11,1.03 [0.83-1.26],0.808955188697639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.96 [0.72-1.3],0.81291066307945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD83,CD83 antigen,Inverse variance weighted,5,1.04 [0.76-1.41],0.814721887326497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.01 [0.92-1.12],0.815381195836674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.05 [0.69-1.59],0.816041785030008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.04 [0.76-1.41],0.816070954196005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.91-1.13],0.821808680355882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.95 [0.57-1.56],0.825365806709047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.99 [0.9-1.09],0.82539588418109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.95 [0.57-1.58],0.833660400918421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.03 [0.78-1.37],0.837348409405797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.98 [0.84-1.15],0.839117037173724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.03 [0.75-1.42],0.83988109775195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.95 [0.55-1.62],0.840378779830557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.01 [0.89-1.16],0.840968710178407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,C7,Complement component C7,Inverse variance weighted,38,0.99 [0.91-1.08],0.842437593637309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,1.07 [0.55-2.07],0.843984310144425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.96 [0.63-1.46],0.852881474380105,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.99 [0.89-1.1],0.856345967514778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.95 [0.58-1.58],0.85699213205098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.01 [0.9-1.14],0.856997498598005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.99 [0.83-1.17],0.862329302706674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.01 [0.92-1.11],0.86319080875309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.92 [0.33-2.51],0.863647886444989,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.02 [0.81-1.29],0.86440158201317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.98 [0.81-1.19],0.868343227110571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.04 [0.66-1.64],0.869199572570136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.99 [0.88-1.11],0.869994558688929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RBP2,Retinol-binding protein 2,Wald ratio,1,0.92 [0.34-2.52],0.870287152559731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.03 [0.75-1.41],0.87071470477925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCN3,CCN family member 3,Inverse variance weighted,19,1.01 [0.85-1.22],0.872993727169221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.97 [0.66-1.42],0.873368745234696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.07 [0.45-2.51],0.879381906448822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.99 [0.82-1.18],0.882631334042273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.11 [0.26-4.71],0.883345144707424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FBLN2,Fibulin-2,Inverse variance weighted,11,1.01 [0.86-1.19],0.884616259858777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.97 [0.62-1.5],0.88710264141379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.01 [0.9-1.13],0.887241878741624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH2,Cadherin-2,Inverse variance weighted,3,0.94 [0.38-2.31],0.894955075259372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.04 [0.57-1.91],0.897172058525304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH6,Cadherin-6,Inverse variance weighted,29,1.01 [0.91-1.11],0.899667448929935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.99 [0.8-1.22],0.904089079952483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.01 [0.81-1.26],0.908223490668104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.02 [0.73-1.42],0.908473131638047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.01 [0.84-1.22],0.913861744071498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.95 [0.37-2.48],0.920739536590267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.01 [0.82-1.25],0.927984608389484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SNCG,Gamma-synuclein,Inverse variance weighted,36,1 [0.91-1.1],0.936065925730869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD48,CD48 antigen,Inverse variance weighted,18,1 [0.91-1.11],0.937532501350538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,0.99 [0.81-1.22],0.940664136703892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.03 [0.46-2.32],0.942191072062623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NTF3,Neurotrophin-3,Inverse variance weighted,8,1.01 [0.78-1.32],0.942597166457139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VWC2,Brorin,Inverse variance weighted,22,1.01 [0.83-1.23],0.945302082164902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.02 [0.59-1.75],0.947805411208846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.99 [0.82-1.2],0.949929643668916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REN,Renin,Inverse variance weighted,4,0.99 [0.71-1.38],0.951076251436555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.99 [0.68-1.44],0.952181383960636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCN5,CCN family member 5,Inverse variance weighted,8,1.02 [0.6-1.73],0.954910225677501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.02 [0.47-2.2],0.959085382504326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL17C,Interleukin-17C,Inverse variance weighted,3,1.01 [0.64-1.59],0.960998407466135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH3,Cadherin-3,Inverse variance weighted,2,0.98 [0.41-2.34],0.964898207188953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AGRP,Agouti-related protein,Inverse variance weighted,3,1.01 [0.54-1.91],0.966150767893155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LPO,Lactoperoxidase,Inverse variance weighted,4,1 [0.8-1.26],0.966285946929271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1 [0.83-1.2],0.968528565071906,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1 [0.86-1.16],0.968563881008651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,1.01 [0.52-1.98],0.968601369571981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EFNA1,Ephrin-A1,Inverse variance weighted,11,1 [0.84-1.19],0.970137845552183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITGA5,Integrin alpha-5,Wald ratio,1,0.98 [0.35-2.77],0.97335953543348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,0.99 [0.66-1.49],0.979253397310816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.99 [0.4-2.43],0.984750407823305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1 [0.8-1.25],0.987569888870237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1 [0.74-1.35],0.989354047853649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1 [0.91-1.1],0.993197546248759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1 [0.78-1.27],0.996848237573269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.36 [0.18-0.69],0.00204969488489512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.69 [0.54-0.89],0.00365826925415079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SELE,E-selectin,Inverse variance weighted,20,0.85 [0.76-0.95],0.00387286729296114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.32 [0.15-0.7],0.0045950501795997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.89 [1.21-2.96],0.00519028819166162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.5 [0.3-0.83],0.00717172176074825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.73 [0.58-0.92],0.00734283143981555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,OGN,Mimecan,Inverse variance weighted,37,0.85 [0.75-0.96],0.00833599419572535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSS,Cathepsin S,Inverse variance weighted,7,0.56 [0.36-0.87],0.0100749394720566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.44 [0.23-0.83],0.0119505435936355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.77 [0.63-0.96],0.017260264105596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.61 [0.39-0.94],0.0240801786487352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.59 [0.38-0.93],0.0241406969136039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.69 [0.5-0.96],0.0255076566949054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,XG,Glycoprotein Xg,Inverse variance weighted,2,0.32 [0.12-0.89],0.0282851374189762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.14 [1.01-1.29],0.0296623453372046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.48 [0.25-0.95],0.0338147618887079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.25 [0.07-0.9],0.033917665677252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,15,0.73 [0.54-0.98],0.0372515999036169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RETN,Resistin,Inverse variance weighted,19,0.77 [0.6-0.99],0.0380745450188821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCN5,CCN family member 5,Inverse variance weighted,12,0.81 [0.66-0.99],0.0418756397786959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,3.88 [1.01-14.89],0.0478523424631132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NTF3,Neurotrophin-3,Inverse variance weighted,11,1.64 [1-2.68],0.0487186677152331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.66 [0.44-1],0.0498671460255226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LCN15,Lipocalin-15,Inverse variance weighted,22,0.89 [0.79-1],0.0517671194672923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.14 [1-1.3],0.0522043562327428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.8 [0.99-3.26],0.0545162666904381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.07 [1-1.15],0.0575033983071035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.56 [0.31-1.02],0.0592710097631579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MUC13,Mucin-13,Inverse variance weighted,3,0.45 [0.2-1.04],0.0613445545947494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,THBD,Thrombomodulin,Inverse variance weighted,11,1.24 [0.99-1.55],0.0636813660651631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FCN1,Ficolin-1,Inverse variance weighted,50,0.9 [0.8-1.01],0.0650315715535131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.61 [0.36-1.03],0.0658541932816888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,2.32 [0.95-5.72],0.0661649048421182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.85 [0.71-1.01],0.0673386067812295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AOC3,Membrane primary amine oxidase,Inverse variance weighted,34,0.9 [0.8-1.01],0.0678255882055686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,1.31 [0.98-1.75],0.0703766946209804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.89 [0.78-1.01],0.0802982203771866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL6,Interleukin-6,Inverse variance weighted,6,0.79 [0.61-1.03],0.0825094573142034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.09 [0.99-1.2],0.0826284849279603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.88 [0.76-1.02],0.0864197575533952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.91 [0.81-1.01],0.0870435971454325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH1,Cadherin-1,Inverse variance weighted,16,0.85 [0.7-1.03],0.0884216534684937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,2.09 [0.88-4.95],0.0941190982469125,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.71 [0.91-3.22],0.0963003360808708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.7 [0.45-1.07],0.0982645300726203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,INSR,Insulin receptor,Inverse variance weighted,5,0.62 [0.35-1.1],0.10087074355762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.71 [0.47-1.07],0.102769011386711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.78 [0.57-1.05],0.105300560343081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRSS8,Prostasin,Inverse variance weighted,14,1.34 [0.94-1.9],0.108572420513087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSL,Cathepsin L1,Inverse variance weighted,29,1.2 [0.96-1.5],0.111152672842032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IMMT,MICOS complex subunit MIC60,Wald ratio,1,2.33 [0.81-6.68],0.114748389125613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD109,CD109 antigen,Inverse variance weighted,36,1.1 [0.98-1.25],0.117406736317657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.54 [0.25-1.17],0.120148618524747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.36 [0.92-2.02],0.124921314653882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LGALS4,Galectin-4,Inverse variance weighted,15,0.88 [0.76-1.04],0.127324033705568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.89 [0.76-1.04],0.13115247647238,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LPO,Lactoperoxidase,Inverse variance weighted,29,0.91 [0.81-1.03],0.131308610535164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,3.24 [0.7-15.08],0.134126585384826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.78 [0.56-1.09],0.141342535914495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.54 [0.23-1.23],0.143297722276872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,APOF,Apolipoprotein F,Inverse variance weighted,8,0.72 [0.46-1.12],0.145180789259596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.17 [0.95-1.45],0.146832499361058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PALM2,Paralemmin-2,Inverse variance weighted,9,1.21 [0.94-1.57],0.147094985751668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.48 [0.87-2.51],0.14984327352464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SLAMF6,SLAM family member 6,Inverse variance weighted,2,2.03 [0.76-5.43],0.158212360000877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.4 [0.87-2.25],0.160951171489837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.93 [0.84-1.03],0.163974272060716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.86 [0.69-1.06],0.166011574450199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,OMD,Osteomodulin,Inverse variance weighted,15,0.85 [0.67-1.07],0.166716999871172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.83 [0.64-1.08],0.16699598352984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.19 [0.93-1.53],0.167633473061678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,WNT9A,Protein Wnt-9a,Wald ratio,1,3.32 [0.6-18.43],0.170313022872058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.92 [0.81-1.04],0.170394955495221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.24 [0.91-1.69],0.171930862573108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MDK,Midkine,Inverse variance weighted,14,1.25 [0.91-1.73],0.172540008756229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,0.54 [0.22-1.33],0.17801228524521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RSPO3,R-spondin-3,Inverse variance weighted,5,0.7 [0.41-1.18],0.178478248010562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NFASC,Neurofascin,Inverse variance weighted,6,0.67 [0.38-1.2],0.180214612457641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BCAN,Brevican core protein,Inverse variance weighted,12,0.78 [0.55-1.12],0.181121401261694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.73 [0.46-1.16],0.182219874566781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.22 [0.91-1.64],0.183486575704327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.93 [0.84-1.03],0.185016400633406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,9,1.23 [0.9-1.68],0.185310516931899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NCAN,Neurocan core protein,Inverse variance weighted,19,0.84 [0.64-1.09],0.190254752248297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.68 [0.38-1.21],0.191072925990311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.16 [0.93-1.46],0.191892095410842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.43 [0.83-2.44],0.194915369236024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.11 [0.95-1.31],0.197325361760678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NOMO1,Nodal modulator 1,Inverse variance weighted,24,0.92 [0.81-1.04],0.197446634431543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.76 [0.49-1.16],0.200271140486381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,2.45 [0.62-9.69],0.203066672082682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD302,CD302 antigen,Inverse variance weighted,11,0.83 [0.62-1.11],0.203690303982704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.81 [0.58-1.12],0.206526634224824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CFC1,Cryptic protein,Inverse variance weighted,11,0.78 [0.52-1.15],0.211926092275637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.18 [0.91-1.53],0.213024920921137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.27 [0.87-1.85],0.221909159979979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.51 [0.17-1.51],0.22234993794741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,0.8 [0.56-1.15],0.224423488304281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.22 [0.88-1.7],0.230085491142929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.14 [0.92-1.4],0.231488994953737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.5 [0.16-1.57],0.233648728728647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,INHBC,Inhibin beta C chain,Inverse variance weighted,12,0.81 [0.56-1.15],0.234649572395478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TMPRSS15,Enteropeptidase,Inverse variance weighted,11,0.86 [0.68-1.1],0.235306296055547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.76 [0.48-1.21],0.246458872553743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.92 [0.8-1.06],0.2503502373107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GUCA2A,Guanylin,Inverse variance weighted,7,0.78 [0.51-1.19],0.250502740635809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.3 [0.82-2.06],0.257755509924569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.26 [0.84-1.88],0.258990406495356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.43 [0.77-2.66],0.259058596600124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.74 [0.66-4.54],0.260597436716103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SEPTIN8,Septin-8,Inverse variance weighted,4,0.73 [0.42-1.27],0.26076549085293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,0.42 [0.09-1.93],0.265195502167776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.8 [0.54-1.19],0.267209299449385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.88 [0.69-1.11],0.274277119930037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LGALS9,Galectin-9,Inverse variance weighted,36,0.92 [0.8-1.07],0.276157173502525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CALCA,Calcitonin,Inverse variance weighted,13,0.81 [0.55-1.2],0.29129069403918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.85 [0.62-1.15],0.292303796267692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.72 [0.38-1.34],0.295250860970987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.33 [0.78-2.27],0.295563701155836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.93 [0.82-1.06],0.296885773742691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.78 [0.48-1.25],0.297970750962258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.82 [0.57-1.19],0.298139957278608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD276,CD276 antigen,Inverse variance weighted,24,0.9 [0.73-1.1],0.298459251759534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.73 [0.4-1.33],0.304369708691028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.86 [0.65-1.15],0.310330669730103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.89 [0.7-1.12],0.311568196221192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.13 [0.89-1.42],0.312345215574034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.16 [0.87-1.53],0.312906767953505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,0.62 [0.25-1.57],0.313120307436412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REN,Renin,Inverse variance weighted,8,1.25 [0.81-1.95],0.314493195748897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.73 [0.4-1.34],0.314574332480454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AREG,Amphiregulin,Inverse variance weighted,5,1.49 [0.69-3.22],0.314934232006843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.83 [0.57-1.2],0.31495974271229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NGRN,Neugrin,Inverse variance weighted,4,0.72 [0.38-1.37],0.315156887326527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.84 [0.6-1.18],0.322191433592157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ZNRD2,Protein ZNRD2,Inverse variance weighted,10,0.81 [0.54-1.23],0.326768220978022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.2 [0.83-1.74],0.329314180698723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.91 [0.75-1.1],0.330239864063644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,0.78 [0.47-1.29],0.333474583232658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLK11,Kallikrein-11,Inverse variance weighted,13,0.86 [0.63-1.17],0.333619711948094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD27,CD27 antigen,Inverse variance weighted,9,1.26 [0.79-2],0.334763170404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.25 [0.79-1.97],0.335491142263332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.63 [0.59-4.48],0.34202892189361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.1 [0.9-1.33],0.342899117392759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSD,Cathepsin D,Inverse variance weighted,7,1.27 [0.77-2.11],0.346474406638851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD99,CD99 antigen,Inverse variance weighted,4,1.38 [0.7-2.73],0.346500405608874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.87 [0.65-1.17],0.348574226725453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MVK,Mevalonate kinase,Wald ratio,1,0.21 [0.01-5.5],0.351935063662253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.94 [0.84-1.07],0.353025252046081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.76 [0.43-1.36],0.357044142828731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.16 [0.85-1.58],0.35903555918769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,1.18 [0.83-1.67],0.360725546613922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.66 [0.27-1.62],0.360844463324348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,UMOD,Uromodulin,Inverse variance weighted,34,1.1 [0.89-1.35],0.363328835615358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,2 [0.44-9],0.366088062733526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.56 [0.16-1.96],0.36632094077441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CFD,Complement factor D,Wald ratio,1,0.56 [0.15-2],0.368170477100612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.31 [0.73-2.34],0.368681064036512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,0.82 [0.53-1.27],0.370293799535634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.27 [0.75-2.18],0.373923033610123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.88 [0.65-1.17],0.3744645572483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.88 [0.65-1.18],0.378172724621067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITGA5,Integrin alpha-5,Inverse variance weighted,18,0.89 [0.69-1.15],0.378174158499405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.67 [0.28-1.63],0.381228340517389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,2.08 [0.4-10.81],0.382227318378879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MILR1,Allergin-1,Inverse variance weighted,43,0.97 [0.9-1.04],0.385380834777696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.07 [0.91-1.27],0.386626639359144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GSN,Gelsolin,Inverse variance weighted,7,1.36 [0.67-2.76],0.38862555966919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AGRP,Agouti-related protein,Inverse variance weighted,16,1.11 [0.87-1.42],0.389041376737762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COLEC12,Collectin-12,Inverse variance weighted,3,1.46 [0.62-3.42],0.389699746956582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.29 [0.72-2.3],0.390028082384078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.08 [0.9-1.3],0.390467506129693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.28 [0.73-2.24],0.391106098275943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.91 [0.74-1.12],0.392541128502763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCN4,CCN family member 4,Inverse variance weighted,29,1.07 [0.91-1.27],0.39340822196518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.77 [0.42-1.4],0.393500242688499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.25 [0.75-2.06],0.394452781263627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.63 [0.22-1.83],0.397214791491908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.13 [0.84-1.53],0.405758215272884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,0.91 [0.72-1.14],0.407825741865742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,0.61 [0.19-1.99],0.415850771289073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.31 [0.68-2.53],0.419083312817492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.25 [0.73-2.13],0.420579649948075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.5 [0.56-4.06],0.420691310559024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.13 [0.84-1.5],0.421076375225802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.78 [0.42-1.44],0.422994556808217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.6 [0.17-2.14],0.426192646041522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH6,Cadherin-6,Inverse variance weighted,5,1.28 [0.7-2.35],0.427767418013967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.79 [0.45-1.41],0.430139677521017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.23 [0.73-2.07],0.437222503121827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD83,CD83 antigen,Inverse variance weighted,14,0.89 [0.65-1.21],0.443364032192674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.89 [0.65-1.21],0.444745656098391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SDC1,Syndecan-1,Inverse variance weighted,12,0.85 [0.56-1.29],0.445827405921323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.77 [0.39-1.52],0.451080481955459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,1.16 [0.79-1.69],0.451599495730506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PVR,Poliovirus receptor,Inverse variance weighted,3,1.78 [0.39-8.05],0.452146491483379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,OCLN,Occludin,Inverse variance weighted,2,1.39 [0.59-3.31],0.452201508735409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1.05 [0.92-1.2],0.45763258479822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH15,Cadherin-15,Inverse variance weighted,4,0.67 [0.23-1.95],0.459467573615132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.25 [0.69-2.28],0.460164179950919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.87 [0.6-1.26],0.461273956621157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,0.9 [0.67-1.2],0.466083175979218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.89 [0.66-1.21],0.466385189362429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.87 [0.6-1.27],0.469791908778284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.94 [0.78-1.12],0.476495987799863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GRN,Progranulin,Inverse variance weighted,46,1.04 [0.93-1.18],0.48207063577402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,0.8 [0.43-1.5],0.483740531309749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.05 [0.92-1.19],0.485265786617009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRELP,Prolargin,Inverse variance weighted,5,0.75 [0.34-1.67],0.485983566341875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MME,Neprilysin,Inverse variance weighted,46,0.96 [0.84-1.08],0.487024773495632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.72 [0.28-1.82],0.489096733154808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,0.93 [0.76-1.14],0.491072105623327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.79 [0.34-9.38],0.49324669729453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.13 [0.79-1.63],0.4933529633331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.67 [0.21-2.11],0.495801432484704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.92 [0.72-1.17],0.502330975681272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.25 [0.65-2.43],0.50272743268347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.21 [0.69-2.13],0.503865802232786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PENK,Proenkephalin-A,Inverse variance weighted,15,1.13 [0.79-1.6],0.50633182110317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.03 [0.94-1.13],0.506494020282021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.87 [0.57-1.32],0.507315303030881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCN3,CCN family member 3,Inverse variance weighted,17,1.07 [0.88-1.29],0.511315376400559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MMP7,Matrilysin,Wald ratio,1,0.83 [0.47-1.45],0.511848526793973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGSF9,Protein turtle homolog A,Inverse variance weighted,2,1.4 [0.51-3.83],0.511879995671775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.85 [0.53-1.37],0.517110222554817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PSAP,Prosaposin,Inverse variance weighted,13,0.92 [0.72-1.18],0.519059271340949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.8 [0.41-1.58],0.519619166926159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.77 [0.35-1.7],0.521349026209201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GCG,Pro-glucagon,Inverse variance weighted,2,1.36 [0.53-3.45],0.521993327565646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.88 [0.59-1.3],0.522270174370166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.69 [0.34-8.55],0.523488116239434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CR1,Complement receptor type 1,Inverse variance weighted,15,0.88 [0.6-1.3],0.525304545903836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.91 [0.67-1.23],0.530111311773865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.12 [0.79-1.58],0.532674870994295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,0.88 [0.59-1.32],0.535809871985241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MFGE8,Lactadherin,Inverse variance weighted,15,1.11 [0.8-1.53],0.537373534470845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITGB7,Integrin beta-7,Inverse variance weighted,42,0.96 [0.84-1.09],0.539186578312639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.65 [0.16-2.64],0.542773192555325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.77 [0.34-1.78],0.54518047067535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.11 [0.79-1.55],0.545807626602686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.58 [0.1-3.48],0.547322038972132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.12 [0.77-1.64],0.55388632175774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.04 [0.91-1.19],0.556572297007052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.24 [0.6-2.59],0.55848844086595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.12 [0.76-1.66],0.559870470462339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.06 [0.87-1.29],0.561181874791558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,0.93 [0.74-1.18],0.56147514394914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.94 [0.78-1.14],0.562006842591301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.08 [0.83-1.42],0.562514372594201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLK4,Kallikrein-4,Inverse variance weighted,5,0.78 [0.33-1.85],0.565400558745218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.11 [0.78-1.56],0.565938347632257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.29 [0.54-3.05],0.567409020879836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1.15 [0.71-1.87],0.568161403592861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.04 [0.92-1.17],0.572136220932288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FAM3D,Protein FAM3D,Inverse variance weighted,38,0.96 [0.83-1.11],0.572390299078326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.09 [0.81-1.46],0.573146029946785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD48,CD48 antigen,Inverse variance weighted,14,0.91 [0.64-1.28],0.57572601954336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.05 [0.88-1.26],0.57993152552279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL11,Eotaxin,Inverse variance weighted,11,0.95 [0.77-1.16],0.585113011154779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.7 [0.2-2.52],0.589048041324705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.89 [0.58-1.37],0.597744071398817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,18,0.93 [0.72-1.21],0.598692763079541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TLR1,Toll-like receptor 1,Wald ratio,1,1.45 [0.34-6.12],0.611218214001204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.76 [0.26-2.21],0.611956381568831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.5 [0.31-7.3],0.613774494776497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.14 [0.69-1.86],0.615404975900394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.94 [0.73-1.21],0.620784052454375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.77 [0.27-2.17],0.621203298472663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.07 [0.81-1.41],0.62326173714437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPON2,Spondin-2,Inverse variance weighted,3,0.81 [0.36-1.86],0.6245041569696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD164,Sialomucin core protein 24,Inverse variance weighted,8,1.14 [0.67-1.94],0.625144106155028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SCG2,Secretogranin-2,Inverse variance weighted,2,1.21 [0.56-2.6],0.628985690989356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHGA,Chromogranin-A,Inverse variance weighted,5,1.15 [0.65-2.05],0.629506933843987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.92 [0.65-1.3],0.630111327766326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,10,0.89 [0.56-1.43],0.631398320584285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.35 [0.4-4.6],0.633081404109894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.94 [0.72-1.23],0.639053634781718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BOC,Brother of CDO,Inverse variance weighted,8,1.1 [0.74-1.64],0.639731679671858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.87 [0.5-1.54],0.640775647586772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.84 [0.39-1.79],0.64905675573032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.97 [0.84-1.11],0.652572969057108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,1.05 [0.84-1.31],0.653874835714665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,1.13 [0.67-1.91],0.655516597789499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.93 [0.68-1.28],0.657288603660164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL19,Interleukin-19,Inverse variance weighted,10,0.95 [0.76-1.18],0.657895394516464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CST3,Cystatin-C,Inverse variance weighted,3,0.7 [0.14-3.52],0.660900184350431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.09 [0.73-1.63],0.668555608051153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DCN,Decorin,Inverse variance weighted,2,1.26 [0.43-3.7],0.668652908016029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PRTG,Protogenin,Inverse variance weighted,8,1.22 [0.48-3.1],0.669360983307891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.98 [0.89-1.08],0.670446053445965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AMBP,Protein AMBP,Inverse variance weighted,5,0.9 [0.55-1.46],0.672072570923033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHGB,Secretogranin-1,Inverse variance weighted,7,1.14 [0.62-2.08],0.67306709506956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.92 [0.61-1.37],0.675330325909951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.88 [0.47-1.64],0.675813912299756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HEPH,Hephaestin,Inverse variance weighted,6,0.94 [0.72-1.24],0.677837448690493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GAST,Gastrin,Inverse variance weighted,9,1.07 [0.77-1.5],0.679023882352463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.93 [0.67-1.3],0.67928755340864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.94 [0.7-1.26],0.682965295398425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.07 [0.76-1.5],0.69126134873435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PALM,Paralemmin-1,Inverse variance weighted,4,0.81 [0.29-2.28],0.691963257275404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH17,Cadherin-17,Inverse variance weighted,31,0.98 [0.87-1.1],0.693057266698874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.11 [0.66-1.86],0.694834280201797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.1 [0.69-1.76],0.695413466688911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.04 [0.85-1.27],0.696777339372063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SLAMF7,SLAM family member 7,Inverse variance weighted,16,0.95 [0.74-1.23],0.707496143820484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ALCAM,CD166 antigen,Inverse variance weighted,4,0.93 [0.62-1.39],0.712982866251209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CHAD,Chondroadherin,Inverse variance weighted,15,1.03 [0.87-1.23],0.713013373148236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PGF,Placenta growth factor,Inverse variance weighted,5,0.9 [0.5-1.62],0.71476422948254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH3,Cadherin-3,Inverse variance weighted,10,1.12 [0.59-2.12],0.722787892523342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPON1,Spondin-1,Inverse variance weighted,4,1.12 [0.6-2.1],0.722918290382142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.11 [0.62-2],0.723368459015528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.92 [0.59-1.44],0.726519592956586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.21 [0.41-3.6],0.730156894413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.92 [0.58-1.46],0.734779951206759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.96 [0.73-1.25],0.736285733033233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.08 [0.69-1.67],0.736343153580322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL17C,Interleukin-17C,Inverse variance weighted,5,0.87 [0.4-1.92],0.738030209824112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.96 [0.75-1.23],0.740077687803583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.08 [0.68-1.73],0.741729227029792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.93 [0.59-1.45],0.741788933469646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.91 [0.5-1.64],0.743013118592878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.98 [0.87-1.11],0.744748958677966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.07 [0.7-1.64],0.744942701130198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.96 [0.77-1.21],0.751901097612938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DSC2,Desmocollin-2,Inverse variance weighted,16,1.03 [0.86-1.23],0.751964538739954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.95 [0.69-1.31],0.752518749243521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.91 [0.52-1.6],0.755952769850274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.13 [0.53-2.41],0.756762225321157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CTSO,Cathepsin O,Inverse variance weighted,19,1.04 [0.82-1.3],0.757756309235989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.92 [0.53-1.58],0.758198802381885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.91 [0.51-1.64],0.75890124279377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.94 [0.64-1.38],0.759207613679096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.12 [0.54-2.35],0.759339539761766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.05 [0.77-1.43],0.762717068921154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.94 [0.62-1.42],0.764914109801919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DPT,Dermatopontin,Inverse variance weighted,4,0.89 [0.43-1.87],0.765049073536639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ITGB2,Integrin beta-2,Inverse variance weighted,20,1.03 [0.82-1.3],0.767205157715949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.95 [0.68-1.33],0.769631951958896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.24 [0.28-5.5],0.775721734973399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.05 [0.75-1.48],0.775828014165836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.95 [0.63-1.42],0.785604427802674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.89 [0.39-2.05],0.787029024726037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Inverse variance weighted,2,0.77 [0.12-4.96],0.787220366259768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.05 [0.76-1.45],0.787290457501355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.97 [0.79-1.2],0.788902699871739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.09 [0.59-1.99],0.792120691921641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PKD1,Polycystin-1,Inverse variance weighted,12,1.05 [0.72-1.54],0.796517062439978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.03 [0.84-1.26],0.79872863124757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.02 [0.86-1.21],0.80158821408054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.96 [0.68-1.35],0.808876797556824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.98 [0.86-1.12],0.809602331630126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.08 [0.58-2],0.810201519330546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.04 [0.77-1.39],0.812020848965027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,0.96 [0.71-1.31],0.812457388587496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.14 [0.39-3.27],0.812647306409069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.91 [0.44-1.92],0.814532792520034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.95 [0.59-1.51],0.815324859187864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.96 [0.66-1.38],0.815474705679064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.89 [0.33-2.4],0.816635532313548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.97 [0.78-1.21],0.817623749519681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD70,CD70 antigen,Inverse variance weighted,11,0.97 [0.77-1.23],0.824740737053348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.93 [0.46-1.86],0.828552661022016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.05 [0.7-1.57],0.829226680108556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.07 [0.58-1.96],0.829694852675411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.95 [0.58-1.55],0.830106413691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.04 [0.73-1.47],0.830347685091097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.93 [0.49-1.76],0.830637512214034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PYY,Peptide YY,Inverse variance weighted,16,0.97 [0.77-1.24],0.833108421472789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,POF1B,Protein POF1B,Inverse variance weighted,4,1.07 [0.55-2.09],0.833954539380576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.97 [0.69-1.34],0.836082675061909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DRAXIN,Draxin,Inverse variance weighted,25,0.98 [0.77-1.24],0.840079908945706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NRP1,Neuropilin-1,Inverse variance weighted,14,0.97 [0.7-1.34],0.841425140294823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.01 [0.91-1.13],0.842065349784708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.95 [0.59-1.55],0.842144417875374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.98 [0.82-1.18],0.843409933660974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.94 [0.53-1.7],0.847284777645652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VWC2,Brorin,Inverse variance weighted,12,0.96 [0.65-1.43],0.848487619396885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD160,CD160 antigen,Inverse variance weighted,24,0.97 [0.71-1.33],0.85300830746464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.88 [0.23-3.33],0.853177427827111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.06 [0.56-2.01],0.857654393633558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.13 [0.29-4.35],0.857862631850168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IL18,Interleukin-18,Inverse variance weighted,26,1.01 [0.87-1.19],0.858243696231375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.19 [0.18-7.72],0.85901902994685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.96 [0.6-1.54],0.86052779916682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,BSG,Basigin,Inverse variance weighted,6,1.05 [0.61-1.79],0.860717968327084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NECTIN2,Nectin-2,Inverse variance weighted,3,1.15 [0.24-5.49],0.863049441815392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.92 [0.33-2.51],0.863647886444989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.96 [0.59-1.55],0.864339788503514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MYL3,Myosin light chain 3,Inverse variance weighted,13,1.04 [0.68-1.59],0.866179975807254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.05 [0.59-1.87],0.869022737112444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.97 [0.66-1.41],0.869154372438092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.06 [0.54-2.07],0.870736071781644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.22 [0.11-13.5],0.871464258627739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.95 [0.47-1.9],0.877165212415161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,1.05 [0.52-2.13],0.881953576461679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,12,1.03 [0.65-1.64],0.885016159398184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.01 [0.88-1.15],0.885548282070328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,0.98 [0.79-1.22],0.888085978200098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CDH2,Cadherin-2,Inverse variance weighted,21,1.02 [0.74-1.41],0.888705983230022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.98 [0.67-1.41],0.896496536603964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.12 [0.21-5.87],0.896497703624175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.99 [0.79-1.23],0.897913319021977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.97 [0.57-1.64],0.899889766105158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.97 [0.59-1.58],0.901438001764467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,0.98 [0.73-1.31],0.901868086094365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,0.97 [0.58-1.61],0.90248525619698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.96 [0.54-1.73],0.903519891437767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.99 [0.86-1.14],0.90543744487738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.99 [0.9-1.1],0.910953239839682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.97 [0.58-1.63],0.912160722620202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,NECTIN4,Nectin-4,Inverse variance weighted,4,0.96 [0.48-1.94],0.913020044837875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CPA2,Carboxypeptidase A2,Inverse variance weighted,10,1.03 [0.66-1.6],0.913029101934433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.02 [0.73-1.43],0.914286877284634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.97 [0.58-1.64],0.915035731589889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.09 [0.21-5.78],0.916202498695514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.99 [0.8-1.22],0.917665805639999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.99 [0.75-1.29],0.922550800577385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.03 [0.55-1.93],0.923817712374581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.98 [0.6-1.59],0.92768824843613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,C7,Complement component C7,Inverse variance weighted,26,1.01 [0.89-1.14],0.929468944624488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.03 [0.55-1.93],0.934398767155641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.98 [0.64-1.51],0.934905384882784,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.99 [0.69-1.41],0.937455167337266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.02 [0.57-1.85],0.937705249833487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,MMP10,Stromelysin-2,Wald ratio,1,0.95 [0.2-4.48],0.951443146855639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.01 [0.82-1.24],0.953620447919732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.99 [0.83-1.19],0.954529750602581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FBLN2,Fibulin-2,Inverse variance weighted,6,1.01 [0.62-1.65],0.956762437646189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.03 [0.33-3.23],0.95810506372279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.01 [0.69-1.48],0.958838551138646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.98 [0.48-2],0.96394830978416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ACY1,Aminoacylase-1,Inverse variance weighted,6,1.01 [0.62-1.65],0.967924928870611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.05 [0.07-15.63],0.970082239394451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.99 [0.48-2.03],0.970660267802562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.99 [0.69-1.42],0.973820489198489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PI3,Elafin,Inverse variance weighted,18,1 [0.84-1.18],0.974467460697518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.01 [0.42-2.46],0.9756480053785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,LAYN,Layilin,Inverse variance weighted,3,1.01 [0.44-2.36],0.97611513081371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.99 [0.61-1.6],0.977704231320018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,AGRN,Agrin,Inverse variance weighted,14,1.01 [0.64-1.58],0.977713632234998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1 [0.83-1.2],0.978678050834828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.99 [0.63-1.57],0.979029887920746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.99 [0.64-1.54],0.979421511770414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CR2,Complement receptor type 2,Inverse variance weighted,36,1 [0.78-1.3],0.979579419084645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,1 [0.74-1.36],0.979628471562011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.99 [0.07-14.05],0.99635170441186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1 [0.7-1.42],0.998077797844406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1 [0.86-1.16],0.999977258737655,trans
